VIG Vienna Insurance Group AG
Vienna Insurance Group AG, together with its subsidiaries, engages in providing insurance products and services in Austria and internationally. The company provides life; health; and property and casualty insurance products, such as medical expense, income protection, worker's compensation, motor vehicle liability, motor own damage, other motor, marine, aviation, transport, fire and other damage to property, general liability, credit and suretyship, legal expenses, assistance, and miscellaneous financial losses insurance. It offers reinsurance products and services, such as Issued and held Treaty reinsurance. It sells its products through direct sales, banks, brokers, and agents. The company was founded in 1824 and is based in Vienna, Austria. Vienna Insurance Group AG is a subsidiary of Wiener Städtische Wechselseitige Versicherungsverein - Vermögensverwaltung - Vienna Insurance Group.…
Industry Peers
Insurance - DiversifiedKey Statistics
About Vienna Insurance Group (VIE: VIG)
›
Vienna Insurance Group (VIE: VIG) is listed on the Vienna Stock Exchange, where its shares trade in EUR. It belongs to the Insurance - Diversified industry, part of the Financial Services sector, and reports about 33,636 employees.
The shares were at 73.50 EUR on 20 November 2026, up 64.6% over 52 weeks. Its 52-week range is 44.05 EUR to 78.40 EUR: the price is 6.3% below the high and 66.9% above the low.
At a market capitalisation of 9.41B EUR, it trades at 6.8 times trailing earnings and 9.3 times forward earnings. The median trailing P/E of its 20 largest Insurance - Diversified peers is 15.5, a discount of 56% for VIG. It pays a dividend yielding 2.31% (it pays out 23% of its earnings), against a median of 3.97% among the dividend payers in that peer group.
Vienna Insurance Group reports return on equity of 11.6%, an operating margin of 10.9% and revenue up 9.2% year over year.
It holds more cash than debt, a net cash position of 12.47B EUR. Its Piotroski F-score is 7 out of 9, a strong reading of its financial health. 4 analysts cover the stock; their mean price target of 71.13 EUR is 3.2% below the current price. The next earnings report is expected on 26 November 2026.